RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
Pharmaceutical Technology
JUNE 6, 2025
wants to ensure the ensuing the US does not lag behind other countries in drug development. The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. Tasos Katopodis / Stringer via Getty Images.
Let's personalize your content